Listar GI- GRINCAR - Artigos por autor "Aldama López, Guillermo"

Mostrando ítems 1-7 de 7

    • A MicroRNA transcription factor blueprint for early atrial arrhytmogenic remodeling 

      Torrado, Mario; Franco, Diego; Lozano-Belasco, Estefanía; Hernández-Torres, Francisco; Calviño-Santos, Ramón; Aldama López, Guillermo; Centeno, Alberto; Castro-Beiras, Alfonso; Mikhailov, Alexander T. (Hindawi, 2015)
      [Abstract] Spontaneous self-terminating atrial fibrillation (AF) is one of the most common heart rhythm disorders, yet the regulatory molecular mechanisms underlying this syndrome are rather unclear. MicroRNA (miRNA) ...

    • Designs and methods for impact evaluation of interventions. Response 

      Aldama López, Guillermo; Muñiz, Javier (Elsevier, 2020-05-12)

    • Impact on mortality after implementation of a network for ST-segment elevation myocardial infarction care: The IPHENAMIC study 

      Aldama López, Guillermo; López, Manuel; Santás-Álvarez, Melisa; Flores-Ríos, Xacobe; Piñón-Esteban, Pablo; Salgado-Fernández, Jorge; Calviño-Santos, Ramón; Vázquez, Nicolás; Mesías, Alejandro; González-Juataney, Carlos; Muñiz, Javier; Vázquez, José Manuel (Elsevier, 2020-02-01)
      [Abstract] Introduction and objectives: Little is known about the impact of networks for ST-segment elevation myocardial infarction (STEMI) care on the population. The objective of this study was to determine whether the ...

    • Presence of Bacterial DNA in Thrombotic Material of Patients with Myocardial Infarction 

      Piñón-Esteban, Pablo; Núñez, Lucía; Moure, Raquel; Marrón Liñares, Grecia Manuela; Flores Ríos, Xacobe; Aldama López, Guillermo; Salgado-Fernández, Jorge; Calviño-Santos, Ramón; Rebollal-Leal, Fernando; Pan Lizcano, Ricardo Francisco; Vázquez-González, Nicolás; Bou, Germán; Tomás, María; Hermida-Prieto, Manuel; Vázquez Rodríguez, José Manuel (Nature Publishing Group, 2020-10-01)
      [Abstract] Infectious agents have been suggested to be involved in etiopathogenesis of Acute Coronary Syndrome (ACS). However, the relationship between bacterial infection and acute myocardial infarction (AMI) has not yet ...

    • Prevalence, etiology, and outcome of catheterization laboratory false alarms in patients with suspected ST-elevation myocardial infarction 

      Barge-Caballero, Eduardo; Vázquez Rodríguez, José Manuel; Estévez-Loureiro, Rodrigo; Barge-Caballero, Gonzalo; Rodríguez-Vilela, Alejandro; Calviño-Santos, Ramón; Salgado-Fernández, Jorge; Aldama López, Guillermo; Piñón-Esteban, Pablo; Campo-Pérez, Rosa; Rodríguez-Fernández, José Ángel; Vázquez-González, Nicolás; Muñiz, Javier; Castro-Beiras, Alfonso (Elsevier, 2010)
      [Abstract] Introduction and objectives. To investigate the prevalence, causes and outcome of catheterization laboratory false alarms (CLFAs) in a regional primary angioplasty network. Methods. A prospective registry of ...

    • Prevalencia, causas y pronóstico de las «falsas alarmas» al laboratorio de hemodinámica en pacientes con sospecha de infarto de miocardio con elevación del segmento ST 

      Barge-Caballero, Eduardo; Vázquez Rodríguez, José Manuel; Estévez-Loureiro, Rodrigo; Barge-Caballero, Gonzalo; Rodríguez-Vilela, Alejandro; Calviño-Santos, Ramón; Salgado-Fernández, Jorge; Aldama López, Guillermo; Piñón-Esteban, Pablo; Campo-Pérez, Rosa; Rodríguez-Fernández, José Ángel; Vázquez-González, Nicolás; Muñiz, Javier; Castro-Beiras, Alfonso (Sociedad Española de Cardiología, 2010)
      [Resumen] Introducción y objetivos. Determinar prevalencia, causas y pronóstico de las «falsas alarmas» al laboratorio de hemodinámica (FALH) en una red regional de angioplastia primaria. Métodos. Registro prospectivo de ...

    • Safety of statins when response is carefully monitored: a study of 336 heart recipients 

      Marzoa Rivas, Raquel; Crespo-Leiro, María Generosa; Paniagua-Martín, María J.; Llinares-García, D.; Muñiz, Javier; Aldama López, Guillermo; Piñón-Esteban, Pablo; Campo-Pérez, Rosa; Castro-Beiras, Alfonso (Elsevier, 2005)
      [Abstract] Background. Statins are used as first-line drugs against hypercholesterolemia after heart transplantation. Randomized clinical trials have shown that they reduce cholesterol levels, and the incidence of rejection ...